FDAClass II · Drug · Recalled June 24, 2026

Cura Hongos recall — Dabur India Limited

Hazard: CGMP Deviations; deficiencies observed during FDA inspection

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID: D-0634-2026
Brand: Dabur India
Classification: Class II
Units affected: 84 tubes
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Description

Cura Hongos, Crema Antifungica, Clotrimazole 1%, 2oz (57g) tubes, Dist by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, UPC 8 52924 00683 1.

Affected products

Cura Hongos

Companies & origin

Recalling firm location: Dadra And Nagar Haveli, India
Firm address: 225 - 4 - 1 Saily Village, Survey No, N/A

Identifying details (verbatim from the notice)

Product codes / lots: Lot# 0003, within expiry
Distribution: US Nationwide.
Firm notified the public via: E-Mail
FDA event ID: 99137
Recall initiated: June 2, 2026
FDA classified: June 26, 2026
FDA report date: June 24, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 12:00 AM UTC.

Report a data error on this page